Skip to main content

AI can diagnose 17 different diseases based on a patient's breath

disease detection based on breath 51506412 ml
Image used with permission by copyright holder
Doctors have been diagnosing certain diseases by sniffing patients’ breath as far back as 400 B.C.

That old methodology could soon get a fresh lease of life, courtesy of new research from the American Chemical Society. What researchers involved with the project have established are unique “breathprint” identifiers for a range of different diseases — including ones like kidney cancer and Parkinson’s disease that you might not immediately assume come with a signature smell.

Recommended Videos

“In this study, we tested the ability of a nano-based intelligent technology to detect and classify a large number of diseases by the analysis of exhaled breath,” Professor Hossam Haick, one of the researchers on the project, told Digital Trends. “We analyzed breath samples obtained from 1,404 subjects, either categorized as healthy controls or having one of 17 different diseases. The nano-based intelligent system was able, after a training phase, to diagnose and classify the samples according to the healthy condition [or] disease of the donor with 86 percent accuracy.”

Please enable Javascript to view this content

The analysis was carried out using a technology called mass spectrometry, a technique in which chemical species are ionized and the ions sorted based on their mass-to-charge ratio. The team discovered that each disease produces a unique volatile chemical scent, based on differing quantities of 13 components.

“Our system is based on an array of nano-materials-based sensors, modified with a sensing organic layer,” Haick continued. “Bioinspired by the mammalian sense of smell, these sensors perform semi-selective analysis of the target volatile molecules in exhaled breath, and with artificial intelligence [are capable of learning and detecting] the unique patterns associated with each disease.”

Impressively, the AI tool is able to detect additional diseases even when one is already present.

Right now, the work exists in the form of a research paper, although Haick said that the plan is to develop a breathalyzer-type portable technology that could be used for early diagnosis in the field. “This is an ongoing process and hopefully soon could reach the daily use in the clinics,” he noted.

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Rivian tops owner satisfaction survey, ahead of BMW and Tesla
The front three-quarter view of a 2022 Rivian against a rocky backdrop.

Can the same vehicle brand sit both at the bottom of owner ratings in terms of reliability and at the top in terms of overall owner satisfaction? When that brand is Rivian, the answer is a resonant yes.

Rivian ranked number one in satisfaction for the second year in a row, with owners especially giving their R1S and R1T electric vehicle (EV) high marks in terms of comfort, speed, drivability, and ease of use, according to the latest Consumer Reports (CR) owner satisfaction survey.

Read more
Hybrid vehicle sales reach U.S. record, but EV sales drop in third quarter
Tesla Cybertruck

The share of electric and hybrid vehicle sales continued to grow in the U.S. in the third quarter, the Energy Information Administration (EIA) reported this month.

Taken together, sales of purely electric vehicles (EVs), hybrids, and plug-in hybrids (PHEVs) represented 19.6% of total light-duty vehicle (LDV) sales last quarter, up from 19.1% in the second quarter.

Read more
Tesla’s ‘Model Q’ to arrive in 2025 at a price under $30K, Deutsche Bank says
teslas model q to arrive in 2025 at a price under 30k deutsche bank says y range desktop lhd v2

Only a short month and half ago, Tesla CEO Elon Musk told investors that outside of the just-released driverless robotaxi, a regular Tesla model priced at $25,000 would be “pointless” and “silly”.

"It would be completely at odds with what we believe,” Musk said.

Read more